Search research articles
Contact Us
Filters
Showing results (31-40 of 51) with videos related to
Page
of 6
Sort By:
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
|
May 3, 2013
Whole body assessment by ¹⁸F-FDG PET in a patient with infective endocarditis
Atsuro Masuda, Osamu Manabe, Masanao Naya, et al.
Oncotarget
|
December 29, 2016
Unsupervised consensus cluster analysis of [18F]-fluoroethyl-L-tyrosine positron emission tomography identified textural features for the diagnosis of pseudoprogression in high-grade glioma
Sied Kebir, Zain Khurshid, Florian C Gaertner, et al.
Oncotarget
|
September 15, 2017
Uptake of PSMA-ligands in normal tissues is dependent on tumor load in patients with prostate cancer
Florian C Gaertner, Khalil Halabi, Hojjat Ahmadzadehfar, et al.
Oncotarget
|
December 22, 2017
Predictors of overall survival in metastatic castration-resistant prostate cancer patients receiving [<sup>177</sup>Lu]Lu-PSMA-617 radioligand therapy
Hojjat Ahmadzadehfar, Stephan Schlolaut, Rolf Fimmers, et al.
Clinical Nuclear Medicine
|
February 28, 2018
[44Sc]Sc-PSMA-617 Biodistribution and Dosimetry in Patients With Metastatic Castration-Resistant Prostate Carcinoma
Ambreen Khawar, Elisabeth Eppard, Jean Phlippe Sinnes, et al.
Clinical Nuclear Medicine
|
April 25, 2018
Prediction of Normal Organ Absorbed Doses for [177Lu]Lu-PSMA-617 Using [44Sc]Sc-PSMA-617 Pharmacokinetics in Patients With Metastatic Castration Resistant Prostate Carcinoma
Ambreen Khawar, Elisabeth Eppard, Jean Phlippe Sinnes, et al.
Clinical Nuclear Medicine
|
April 2, 2019
Peptide Receptor Radionuclide Therapy Combined With Chemotherapy in Patients With Neuroendocrine Tumors
Anna Yordanova, Harriet Ahrens, Georg Feldmann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 19, 2013
Preclinical evaluation of 18F-LMI1195 for in vivo imaging of pheochromocytoma in the MENX tumor model
Florian C Gaertner, Tobias Wiedemann, Behrooz H Yousefi, et al.
Plos One
|
May 30, 2009
Treatment of peritoneal carcinomatosis by targeted delivery of the radio-labeled tumor homing peptide bi-DTPA-[F3]2 into the nucleus of tumor cells
Enken Drecoll, Florian C Gaertner, Matthias Miederer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 7, 2013
Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesions
Matthias Eiber, Toshiki Takei, Michael Souvatzoglou, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 51) with videos related to
Sort By:
Page
of 6
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
|
May 3, 2013
Whole body assessment by ¹⁸F-FDG PET in a patient with infective endocarditis
Atsuro Masuda, Osamu Manabe, Masanao Naya, et al.
Oncotarget
|
December 29, 2016
Unsupervised consensus cluster analysis of [18F]-fluoroethyl-L-tyrosine positron emission tomography identified textural features for the diagnosis of pseudoprogression in high-grade glioma
Sied Kebir, Zain Khurshid, Florian C Gaertner, et al.
Oncotarget
|
September 15, 2017
Uptake of PSMA-ligands in normal tissues is dependent on tumor load in patients with prostate cancer
Florian C Gaertner, Khalil Halabi, Hojjat Ahmadzadehfar, et al.
Oncotarget
|
December 22, 2017
Predictors of overall survival in metastatic castration-resistant prostate cancer patients receiving [<sup>177</sup>Lu]Lu-PSMA-617 radioligand therapy
Hojjat Ahmadzadehfar, Stephan Schlolaut, Rolf Fimmers, et al.
Clinical Nuclear Medicine
|
February 28, 2018
[44Sc]Sc-PSMA-617 Biodistribution and Dosimetry in Patients With Metastatic Castration-Resistant Prostate Carcinoma
Ambreen Khawar, Elisabeth Eppard, Jean Phlippe Sinnes, et al.
Clinical Nuclear Medicine
|
April 25, 2018
Prediction of Normal Organ Absorbed Doses for [177Lu]Lu-PSMA-617 Using [44Sc]Sc-PSMA-617 Pharmacokinetics in Patients With Metastatic Castration Resistant Prostate Carcinoma
Ambreen Khawar, Elisabeth Eppard, Jean Phlippe Sinnes, et al.
Clinical Nuclear Medicine
|
April 2, 2019
Peptide Receptor Radionuclide Therapy Combined With Chemotherapy in Patients With Neuroendocrine Tumors
Anna Yordanova, Harriet Ahrens, Georg Feldmann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 19, 2013
Preclinical evaluation of 18F-LMI1195 for in vivo imaging of pheochromocytoma in the MENX tumor model
Florian C Gaertner, Tobias Wiedemann, Behrooz H Yousefi, et al.
Plos One
|
May 30, 2009
Treatment of peritoneal carcinomatosis by targeted delivery of the radio-labeled tumor homing peptide bi-DTPA-[F3]2 into the nucleus of tumor cells
Enken Drecoll, Florian C Gaertner, Matthias Miederer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 7, 2013
Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesions
Matthias Eiber, Toshiki Takei, Michael Souvatzoglou, et al.
Page
of 6